These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease. Hahn DL N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868 [No Abstract] [Full Text] [Related]
26. Letter: Sch 1000: a new anticholinergic bronchodilator. Segal MS Am Rev Respir Dis; 1976 Jun; 113(6):893. PubMed ID: 132884 [No Abstract] [Full Text] [Related]
27. Reversible airflow obstruction: clinical spectrum and responsiveness to anticholinergic drugs. Jolobe OM Respiration; 1984; 45(3):232-6. PubMed ID: 6235558 [TBL] [Abstract][Full Text] [Related]
28. [New developments in the field of bronchospasmolytics]. Nolte D Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306 [No Abstract] [Full Text] [Related]
31. [When are bronchodilator agents sufficient in asthma/chronic obstructive lung disease?]. Ponsioen BP Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2390-1. PubMed ID: 7501082 [No Abstract] [Full Text] [Related]
32. Airflow limitation--reversible or irreversible. Lancet; 1988 Jan 2-9; 1(8575-6):26-7. PubMed ID: 2891892 [No Abstract] [Full Text] [Related]
33. Inhaled beclomethasone improves the course of asthma and COPD. Dompeling E; van Schayck CP; Molema J; Folgering H; van Grunsven PM; van Weel C Eur Respir J; 1992 Sep; 5(8):945-52. PubMed ID: 1426202 [TBL] [Abstract][Full Text] [Related]
34. Inhaled corticosteroids in COPD: the EUROSCOP study in perspective. Yernault JC Eur Respir J; 1992 Nov; 5(10):1169-70. PubMed ID: 1486959 [No Abstract] [Full Text] [Related]
35. [Use of dosage-aerosols in the treatment of obstructive respiratory tract diseases]. Frank A Wien Med Wochenschr; 1977 May; 127(10):309-13. PubMed ID: 141791 [No Abstract] [Full Text] [Related]
36. Drug strategies for airflow obstruction. Petty TL Am J Nurs; 1987 Feb; 87(2):180-4. PubMed ID: 2880508 [No Abstract] [Full Text] [Related]
37. [Ventilatory and associated effects of a synthetic anticholinergic, SCH 1,000, in obstructive bronchopathies]. Pelucco D; Cerri E; Di Muzio M; Rossi GA Bronchopneumologie; 1976; 26(5):399-409. PubMed ID: 137769 [No Abstract] [Full Text] [Related]
38. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid]. Vestbo J; Lange P Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457 [No Abstract] [Full Text] [Related]
39. Anticholinergic and beta-sympathomimetic inhalation challenges in asthma and bronchitis. Marcq M; Minette A Acta Tuberc Pneumol Belg; 1976; 67(3-4):156-62. PubMed ID: 1016524 [No Abstract] [Full Text] [Related]
40. [Eight parameters of ventilatory function in evaluating the therapeutic effects of bronchodilators]. Huang ZB Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):29-32. PubMed ID: 6430490 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]